Opko Health Inc (OPK)

[Pennyes]

Opko is undervalued!..perhaps 10x or more undervalued!.

We believe BioReference ("BRL") is worth $3 billion to $6 billion given its true annual earnings power is between $300 million and $400 million.

Today on OPKO's earnings call, investors and sell-side analysts will have the ability to ask management important questions. We believe if investors ask these questions and read through our presentation, they will have little trouble in understanding the staggering disconnect between OPKO's current trading value and its current market value:

Do you believe Somatrogon can produce a 9-figure royalty stream, and given OPKO is not getting anywhere near the true value for the asset today, would you consider selling some of the royalty, which would bring in near-term cash to be used to purchase undervalued shares back, a dividend or other accretive uses? If so, do you believe there is interest for these assets?
https://www.barchart.com/story/stocks/quotes/OPK/overview/534968/sian-capital-highlights-paths-to-meaningful-value-creation-at-opko-health